AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Finance & Markets
US Offers 40 Million Barrels From Strategic Oil Reserve As Energy Markets Face Supply Pressures
The United States has offered energy companies access to up to 40 million barrels of crude oil from its Strategic Petroleum Reserve (SPR), marking the final phase of an international agreement to…
Global Investors Sell Indian Assets Amid Rising Oil Prices And Yields
The renewed selling is snuffing out a nascent recovery in foreign demand following an unprecedented stretch of underperformance by Indian stocks against regional peers.
Australian shares edge higher, head for worst month in six; inflation data in focus
Australian shares edged up on Wednesday but were headed for their worst monthly decline in six months as investors stayed on the sidelines ahead of domestic inflation data due later in the day.
Another IPO Record? Despite Sensex Slump, Over 200 Companies Ready For Market Debut
About 144 companies have already received regulatory approvals to launch IPOs, including Oravel Stays Ltd., Torrent Gas Ltd. and Sify Infinit Spaces.
